Showing results (151-160 of 271) with videos related to
Sort By:
Pageof 28
American Heart Journal|March 30, 2002
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonistsWojciech Mazur, Grzegorz L Kaluza, Shelly Sapp, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCAZachary S Yaker, A Michael Lincoff, Leslie Cho, et al.The American Journal of Cardiology|April 26, 2008
Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitusMasashi Kimura, Gary S Mintz, Neil J Weissman, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 15, 2009
Drug-eluting stent fracture and acute coronary syndromeAdnan K Chhatriwalla, Akin Cam, Samuel Unzek, et al.Journal of the American College of Cardiology|April 20, 2005
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trialJeffrey W Moses, Roxana Mehran, Eugenia Nikolsky, et al.American Journal of Epidemiology|April 20, 2007
Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities StudyAlanna C Morrison, Lance A Bare, Lloyd E Chambless, et al.Journal of Interventional Cardiology|December 21, 2007
A randomized trial of 5 versus 7 French guiding catheters for transfemoral percutaneous coronary stent implantationJorge R Büchler, Expedito E Ribeiro, João L Falcão, et al.JACC. Cardiovascular Interventions|February 5, 2010
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)Stephen G Ellis, Gregg W Stone, David A Cox, et al.Lancet (London, England)|January 31, 2016
1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysisGregg W Stone, Runlin Gao, Takeshi Kimura, et al.Journal of the American College of Cardiology|February 27, 2007
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?Mehdi H Shishehbor, Michael S Lauer, Inder M Singh, et al.Pageof 28